Menu
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
We believe in personalized treatments tailored to your unique cancer and genes. Our tests are designed to pinpoint the most effective treatment options for your cancer journey!
Following your 30-minute value-packed consultation, our dedicated team curates the tests and therapies to support your cancer condition.
Through our comprehensive and personalized analysis, optimize your cancer journey. We are here to help you in the fight against cancer.
RGCC Followup tests monitor patients cancer at molecular level and its response to various treatments and help in early detection of cancer recurrence and relapse.
RGCC’s comprehensive tests are equipped to assess the sensitivity and determine the effectiveness of chemotherapeutic drugs and natural substances that are developed to fight the cancer.
RGCC’s advanced tests are designed to provide information on drug response, detect chromosomal abnormalities, assess the immune system, and anticipate cancer metastasis.
RGCC CAMBISeq®, using the next generation sequencing technique, the test offers a detailed insight into various cancers like Breast, Sarcoma, Melanoma, GI, etc. enabling to determine the most effective immunotherapies and treatments for those cancers.
RGCC Onco-D-clare detects cancer before the symptoms and enables individuals to take proactive measures towards their health.
Every cancer is unique. So, individualized treatment is necessary to help patients win their battle against cancer. Through our steadfast commitment to cancer care and range of tests and therapies, we have improved outcomes for patients across the globe.
RGCC Testing provides valuable information about your cancer’s genetic profile, allowing our medical team to partner with your oncologist to design personalized treatment plans that target your specific cancer characteristics
RGCC has received prestigious recognition as one of the top 10 Swiss Biotech companies in 2023 by Life Sciences Review. Proudly standing alongside Switzerland’s esteemed biotech leaders, this acknowledgment underscores our unwavering commitment to innovation, excellence, and our continual contribution to the life sciences sector.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our doctors to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
We provide comprehensive and personalized analysis that has helped countless patients in their battle against cancer. Using the tools and expertise from RGCC, we deliver precise results for personalized treatment decisions to enhance outcomes.
RGCC's ChemoSNiP test guides my treatment decisions with precision. It helps me tailor chemotherapy regimens to each patient's genetic profile, improving efficacy and minimizing side effects. It's an essential tool in personalized cancer care.
RGCC's Onco-D-clare test is a breakthrough in early cancer detection. Its accuracy enables timely intervention, improving patient prognosis and overall survival rates. A critical tool in cancer screening and prevention.
Immune-Frame test provides invaluable insights into a patient's immune status. By evaluating immune function, I can tailor therapies to enhance immune response against cancer, improving treatment outcomes and patient quality of life.
"With RGCC's Onconomics Extracts Plus test, I can assess the effectiveness of natural substances with precision, incorporating gene expression analysis for personalized treatment planning. This holistic approach enhances treatment outcomes and empowers patients to explore natural therapies tailored to their needs. A game-changer in integrative oncology."
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.
RGCC tests like Metastat accurately detect the development of secondary tumors.
Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells.
Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.
Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.
Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.
Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.
Indeed, tests are designed to reveal whether cancer cells are resistant or sensitivity to specific drugs and treatments.
If you’re looking for the right tools to navigate cancer with ease, RGCC tests are your solution. We offer cutting-edge diagnostics and personalized tests to combat your cancer and enhance the outcome of your treatment. With our expertise and dedication, we’re committed to making a meaningful difference in the fight against cancer.
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
Copyright 2024 © All Right Reserved.
Designed by Bee High Media
